Advanced search
Publication Cover
Leukemia & Lymphoma Volume 10, 1993 - Issue sup1
Submit an article Journal homepage
54
Views
21
CrossRef citations to date
0
Altmetric
Original Article

High-Dose Versus Intermediate Dose Cytosine Arabinoside Combined with Mitoxantrone for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia: Results of an Age Adjusted Randomized Comparison

W. Hiddemann Department of Hematology and Oncology, Univ. of Göttingen, Germany
,
C. Aul Department of Hematology and Oncology, Univ. of Göttingen, Düsseldorf, Germany
,
G. Maschmeyer Department of Hematology and Oncology, Univ. of Göttingen, Evangelisches Krankenhaus, Essen-Werden, Germany
,
R. Schönrock-nabuls Department of Hematology and Oncology, Univ. of Göttingen, Germany; Department of Hematology and Oncology, Univ. of Göttingen, Krankenhaus St. Georg HamburgGermany
,
W. D. Ludwig Department of Hematology and Oncology, Univ. of Göttingen, Berlin, Germany
,
A. Bartholomäus Department of Hematology and Oncology, Univ. of Göttingen, St. Bernward Krankenhaus HildesheimGermany
,
P. Bettelheim Department of Hematology and Oncology, Univ. of Göttingen, Vienna, Germany
,
K. Becker Department of Hematology and Oncology, Univ. of Göttingen, Hamberg, Germany
,
L. Balleisen Department of Hematology and Oncology, Univ. of Göttingen, Evangelisches Krankenhaus, Hamm, Germany
,
B. Lathan Department of Hematology and Oncology, Univ. of Göttingen, Cologne, Germany
,
H. Köppler Department of Hematology and Oncology, Univ. of Göttingen, Marburg, Germany
,
T. Grüneisen Department of Hematology and Oncology, Univ. of Göttingen, Städtisches Krankenhaus, Neukölln-Berlin, Germany
,
R. Donhuijsenant Department of Hematology and Oncology, Univ. Of GÖTtingen, St. Johannis-Hospital, Duisburg-Hamborn, Germany
,
A. Reichle Department of Hematology and Oncology, Univ. of Göttingen, Munich, Germany
,
A. Heinecke Dept. Biostatistics, Univ. of Münster, Germany
,
C. Sauerland Dept. Biostatistics, Univ. of Münster, Germany
&
Th. Büchner Department of Hematology and Oncology, Univ. of Göttingen, Münster, Germany
 show all
Pages 133-137 | Published online: 01 Jul 2009

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Ciara Freeman, Niamh Keane, Ronan Swords & Francis Giles. (2013) Vosaroxin: a new valuable tool with the potential to replace anthracyclines in the treatment of AML?. Expert Opinion on Pharmacotherapy 14:10, pages 1417-1427.
Read now
Luisa Mantovani, Dirk Hasenclever, Rainer Krahl, Wolfram Pönisch, Michael Herold, Rita Pasold, Friedrich Fiedler, Gottfried Dölken, Dietrich Kämpfe, Hans Joachim Schmoll, Rita Súbert, Martin Kubel, Dietger Niederwieser & Werner Helbig. (2002) Intermediate-dose Cytarabine Treatment Delivered at Moderate Infusion Rates for De Novo Acute Myeloid Leukemia-Results of a phase I-II Study. Leukemia & Lymphoma 43:2, pages 265-274.
Read now
Javier De La Sernas, Jose Francisco Tomás, Carlos Solano, Maria Luisa García De Paredes, Joaquín Campbell, Carlos Grande & Joaquín Diaz-Mediavilla. (1997) Idarubicin and intermediate dose ARA-C followed by consolidation chemotherapy or bone marrow transplantation in relapsed or refractory acute myeloid leukemia. Leukemia & Lymphoma 25:3-4, pages 365-372.
Read now
James F. Bishop. (1996) Intensified Induction and Post-Remission Therapy for Acute Myeloid Leukaemia. Hematology 1:2, pages 91-102.
Read now

Articles from other publishers (17)

Renato Bassan, Tamara IntermesoliArianna MasciulliChiara PavoniCristina Boschini, Giacomo GianfaldoniFilippo MarmontIrene CavattoniDaniele MatteiElisabetta TerruzziLorella De PaoliChiara CattaneoErika BorlenghiFabio CiceriMassimo BernardiAnna M. ScattolinElisabetta TodiscoLeonardo CampiottiPaolo CorradiniAgostino CortelezziDario FerreroPamela ZanghìElena OldaniOrietta SpinelliErnesta AudisioSergio CortelazzoAlberto BosiBrunangelo Falini, Enrico M. PoglianiAlessandro Rambaldi. (2019) Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML. Blood Advances 3:7, pages 1103-1117.
Crossref
Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, Miguel Ángel Sanz & Pau Montesinos. (2018) Salvage regimens using conventional chemotherapy agents for relapsed/refractory adult AML patients: a systematic literature review. Annals of Hematology 97:7, pages 1115-1153.
Crossref
Farhad Ravandi, Ellen K Ritchie, Hamid Sayar, Jeffrey E Lancet, Michael D Craig, Norbert Vey, Stephen A Strickland, Gary J Schiller, Elias Jabbour, Harry P Erba, Arnaud Pigneux, Heinz-August Horst, Christian Recher, Virginia M Klimek, Jorge Cortes, Gail J Roboz, Olatoyosi Odenike, Xavier Thomas, Violaine Havelange, Johan Maertens, Hans-Günter Derigs, Michael Heuser, Lloyd Damon, Bayard L Powell, Gianluca Gaidano, Angelo-Michele Carella, Andrew Wei, Donna Hogge, Adam R Craig, Judith A Fox, Renee Ward, Jennifer A Smith, Gary Acton, Cyrus Mehta, Robert K Stuart & Hagop M Kantarjian. (2015) Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study. The Lancet Oncology 16:9, pages 1025-1036.
Crossref
Ramon V. Tiu & Mikkael A. Sekeres. (2014) Making sense of the myelodysplastic/myeloproliferative neoplasms overlap syndromes. Current Opinion in Hematology 21:2, pages 131-140.
Crossref
Rafael BejarRamon V. TiuMikkael A. SekeresRami S. Komrokji. (2013) Myelodysplastic Syndromes: Recent Advancements in Risk Stratification and Unmet Therapeutic Challenges. American Society of Clinical Oncology Educational Book:33, pages e256-e270.
Crossref
G Juliusson, R Billström, A Gruber, E Hellström-Lindberg, M Höglund, K Karlsson, D Stockelberg, A Wahlin, M Åström, C Arnesson, U Brunell-Abrahamsson, J Carstensen, E Fredriksson, E Holmberg, K Nordenskjöld & F Wiklund. (2005) Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survival. Leukemia 20:1, pages 42-47.
Crossref
Simon Daenen, Bronno van der Holt, Gregor E.G Verhoef, Bob L?wenberg, Pierre W Wijermans, Peter C Huijgens, Rien van Marwijk Kooy, Harry C Schouten, Mark H.H Kramer, Augustin Ferrant, Eva van den Berg, Monique M.C Steijaert, Leo F Verdonck & Pieter Sonneveld. (2004) Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia:. Leukemia Research 28:10, pages 1057-1067.
Crossref
Gunnar Juliusson, Martin Höglund, Karin Karlsson, Christina Löfgren, Lars Möllgård, Christer Paul, Ulf Tidefelt & Magnus Björkholm. (2003) Increased remissions from one course for intermediate-dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine. A randomized population-based phase II study. British Journal of Haematology 123:5, pages 810-818.
Crossref
Xing-Yue He, Paul Elson, Brad Pohlman, Alan Lichtin, Mohamad Hussein, Steve Andresen & Matt Kalaycio. (2002) Timed sequential chemotherapy with concomitant Granulocyte Colony-Stimulating Factor for high-risk acute myelogenous leukemia: a single arm clinical trial. BMC Cancer 2:1.
Crossref
John M. Bennett, Mary S. Young, Jane L. Liesveld, Elisabeth Paietta, Kenneth B. Miller, Hillard M. Lazarus, Robert D. Marsh, William R. Friedenberg, Hussain T. Saba, F. Ann Hayes, Gordon W. Dewald, Wolfgang Hiddemann & Jacob M. Rowe. (2001) Phase II study of combination human recombinant GM-CSF with intermediate-dose cytarabine and mitoxantrone chemotherapy in patients with high-risk myelodysplastic syndromes (RAEB, RAEBT, and CMML): An Eastern Cooperative Oncology Group Study. American Journal of Hematology 66:1, pages 23-27.
Crossref
Franz von Bruchhausen, Siegfried Ebel, Eberhard Hackenthal, Ulrike Holzgrabe, Margitta Albinus, Gudrun Amschler, Erwin von Angerer, C. Arras-Reiter, Andrea Bauer, Pia Bauer, Winfried Beil, Thorsten Beyrich, Katja Binder, Roswitha Böhme, Hans-Hubertus Borchert, Franz Bossle, Franz Bracher, Helmut Bräunlich, Ellen Bretschneider, Regina Brigelius-Flohé, Kerstin Brinkmann, Axel Büge, Wolfram Christ, Monika Cimbollek, Rolf Daniels, Gerd Dannhardt, Hans-Jürgen Duchstein, Kurt Eger, Petra Eichhorn, Michael Engler, Thomas Erker, Peter Felfe, Alfred Fenyves, Reinhard Fescharek, Carmen Frackenpohl, August Wilhelm Frahm, Margarete Frahm, Volker Franke, Ulrich Franken, Detlef Geffken, Uli Geis, Erika Glusa, Berthold Göber, Peter Ndive Gobina, Werner Golder, Margarete Goppelt-Strübe, Katharina Götte, Erkme Gottstein, Michael Grosam, Markus von Gruchalla, Michael Gütschow, Annette Häfner, Boris Haluszczynski, Achim Harder, Sabine Hartmann, Susanne Hartmann, Dieter Heber, Gerhard Heinemeyer, Eberhard Heller, Dietrich von Herrath, J. Hilfenhaus, Ute Hoffmann-Schollmayer, Bernhard Hofmann, Christian Holpert, Ute Hübner-Steiner, Elisabeth Inkmann, Jens Jürgens, Brigitte Kaiser, Dieter-Abbo Kalbhen, Hans Kemmler, Werner Kiefer, Christoph Klett, Stephanie Klett, Martin Klingmüller, Hans-Peter Klöcking, Gerd Kobal, Axel Kramer, Mareta Kreher, M. Krüger, Markus Kuhn, Marion Sylvia Lehner, Detlef Leopoldt, Georg Liedtke, Detlef Manns, Wolfgang Matthiessen, Andreas Maurer, Wolfgang Meindl, Klaus Menges, Paul Messinger, Frank Peter Meyer, Wolfgang Meyerhof, Manfred Moos, Rudolf Morgenstern, Klaus Müller, Walter E. Müller, Corina Nachtsheim, Tilo Netzer, Michael Neugebauer, Werner Neupert, Peter Nickel, Peter Nuhn, Bernd Nürnberg, H. Oelschläger, Joachim Oertel, Michael Oettel, Hartmut Oßwald, Robert Ott, Tilmann Ott, Thomas Otzen, Peter Pachaly, Helmut Pelzer, Karl-Uwe Petersen, Rainer Pick, Martina Pickert, Andreas Pies, Eberhard Reimann, Joachim Richter, Kai Riecke, Suzanne Ritter, Hans Rommelspacher, Ulrich Rose, Gernot Roth, Gerhard Rücker, Judith Schäfer, Joachim G. Schantl, Helmut Schlager, Hildegard Schleinitz, Max Schmauß, Helmut Schmidhammer, Gerhard Schmidt, Timo Schmidt, B. Schneeweiß, Johannes Schräder, Thomas Schulz, Gert Schulze, Peter Schwanz, Johannes Schweiger, Gisela Skopp, Gisela Skorka, Kai Smolinka, Ulrich Speck, Ralf Stahlmann, Herbert Stein, Karlheinz Stiefvater, Karl-Heinz Surborg, Ulf Sürig, Hubert Szelényi, Istvan Szelenyi, Alfred Täufel, Ruth Thieroff-Ekerdt, Reinhard Troschütz, Michael Verborg, Eugen J. Verspohl, Sabine Vogel, Franz-Josef Volk, Thomas Vorwerk, Jürgen Wallmann, Martin Wenzel, Marion Weyandt-Spangenberg, Sandra Wich, Reinhold Wintersteiger, Frauke Woltmann, Beate Wüst, G. Zilow & A. Kluge. 1999. Hagers Handbuch der Pharmazeutischen Praxis. Hagers Handbuch der Pharmazeutischen Praxis 71 233 .
R. Advani, G. Visani, D. Milligan, H. Saba, M. Tallman, J. M. Rowe, P. H. Wiernik, J. Ramek, K. Dugan, B. Lum, J. Villena, E. Davis, E. Paietta, M. Litchman, A. Covelli, B. Sikic & P. Greenberg. 1999. Drug Resistance in Leukemia and Lymphoma III. Drug Resistance in Leukemia and Lymphoma III 47 56 .
Fleischhack, Hasan, Graf, Mann & Bode. (2001) IDA‐FLAG (idarubicin, fludarabine, cytarabine, G‐CSF), an effective remission‐induction therapy for poor‐prognosis AML of childhood prior to allogeneic or autologous bone marrow transplantation: experiences of a phase II trial. British Journal of Haematology 102:3, pages 647-655.
Crossref
J. Braess, D. Berkovic, M. Feuring-Buske, E. Fleer, J. Pförtner, C. Wegendt, S. Keye, J. Riggert, W. Kern, M. Unterhalt, W. Hiddemann & E. Schleyer. 1998. Acute Leukemias VII. Acute Leukemias VII 596 602 .
W. Hiddemann, W. Kern, B. Wörmann & Th. Büchner. 1998. Acute Leukemias VII. Acute Leukemias VII 932 935 .
W. Verbeek, B. Wörmann, P. Koch, C. Aul, H. Hinrichs, J. Balleisen, J. Bennett, T. Büchner & W. Hiddemann. 1997. Acute Leukemias VI. Acute Leukemias VI 908 911 .
W. Hiddemann, M. Unterhalt, M. Kemper, E. Schleyer, P. Schönrock-Nabulsi, L. Uharek, M. Fromm, D. Braumann, M. Planker, U. Kubicka, J. Karow, S. Lange, C. Tirier, B. Wörmann, C. Sauerland, A. Heinecke & Th. Büchner. 1996. Acute Leukemias V. Acute Leukemias V 195 199 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.